Thursday, January 06, 2011 1:33:25 AM
ZERO...I don't know if your any kind of expert in this field...but I need some help here from you all...Listen to this and see if i'm right in thinking part of Viropro..is in the same ballpark as BVTI...They seem pretty similiar other than market cap...
This is VIROpro's site...note the last sentence...
The innovative business strategy of Viropro is based on the acquisition of exclusive products and technological licenses/patents, simultaneously with the development of key partnerships with pre-eminent players on a national and international scale. Viropro has already concluded an agreement with the Biotechnological Research Institute of the National Council of Canada (Montreal: Worldwide exclusive rights to the use of patented expression systems for the production of human Interferon beta and monoclonal antibodies; scale-up and production processes).
Now this from BVTI 2nd paragraph about Monoclonel Anitbodies..etc..
http://www.bizjournals.com/stlouis/news/2010/12/20/biovest-gets-350000-contract.html?ana=yfcpc
sounds pretty similiar...
but take a look at the market cap Difference of the 2.... BVTI does have a drug or 2 in the pipeline i think..but no deals with major pharma i dont' think,,but i could be wrong...
But BVTI is sporting a 100 Million dollar market cap,,and sitting like a rock at .90 a share...could this be an example of where VPRO Is headed?
I don't just looking for something realistic to compare VPRO to based on business model etc...but of course each company is different...just thought they had alot of similarities..OTHER THAN MARKET CAP...which is currently being corrected...
mj
This is VIROpro's site...note the last sentence...
The innovative business strategy of Viropro is based on the acquisition of exclusive products and technological licenses/patents, simultaneously with the development of key partnerships with pre-eminent players on a national and international scale. Viropro has already concluded an agreement with the Biotechnological Research Institute of the National Council of Canada (Montreal: Worldwide exclusive rights to the use of patented expression systems for the production of human Interferon beta and monoclonal antibodies; scale-up and production processes).
Now this from BVTI 2nd paragraph about Monoclonel Anitbodies..etc..
http://www.bizjournals.com/stlouis/news/2010/12/20/biovest-gets-350000-contract.html?ana=yfcpc
sounds pretty similiar...
but take a look at the market cap Difference of the 2.... BVTI does have a drug or 2 in the pipeline i think..but no deals with major pharma i dont' think,,but i could be wrong...
But BVTI is sporting a 100 Million dollar market cap,,and sitting like a rock at .90 a share...could this be an example of where VPRO Is headed?
I don't just looking for something realistic to compare VPRO to based on business model etc...but of course each company is different...just thought they had alot of similarities..OTHER THAN MARKET CAP...which is currently being corrected...
mj

